September is Childhood Cancer Awareness Month. The most common type of childhood cancer is acute lymphocytic leukemia (ALL), ...

Clinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early ...

RNA-sequencing has become a cornerstone in the study of gene expression, offering insights beyond mere mRNA transcript ...

Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early ...

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

In this retrospective review, published in Blood Advances, 58 patients with hematologic malignancies who received CAR-T cell therapy in the outpatient setting during 2022 to 2023 were analyzed. Among ...

One key project is a study on CAR-T cell therapy for chronic lymphocytic leukaemia. The Indian Council of Medical Research ...

South Carolina made significant progress over 25 years in helping kids with cancer survive. But a Daniel Island patient shows ...

Amrita Hospital, Faridabad, has launched a Centre of Excellence for CAR T-Cell Therapy to treat specific blood cancers like B ...

PhD Defense: Towards optimal therapy intensity in pediatric acute lymphoblastic leukemia; The right dose for the right patient ...